Drug intelligence / Profile preview

Revito

Development stage: Unknown
Lead developer: Pax Vedic Science
Administration: Oral

Overview

**Revito** is an oral multi-herb Ayurvedic capsule product marketed by Pax Vedic Science for anxiety, depression, stress relief, stamina, memory enhancement, and brain function support. The company identifies the formulation as containing Akarkara, Ashwagandha, Gokhru, Kaunch Beej, and Safed Musli; it does not disclose a defined molecular target, validated pharmacologic mechanism, or clinical development program. ([paxvedicscience.com](https://www.paxvedicscience.com/ayurveda-and-stress-management-finding-inner-peace-and-harmony/))

Brand names: Revito

Beyond the preview

Go deeper on Revito.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revito.

Explore the full profile